Excretion of [6-14C]megestrol acetate (6 methyl-17 acetoxypregna-4,6 diene, 3,20 dione) released from subcutaneous silastic implants in women.
D003270:Contraceptive Agents / Q000008:administration & dosage; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008535:Megestrol / Q000008:administration & dosage / Q000652:urine; D011278:Pregnanes / Q000008:administration & dosage* / Q000652:urine*; D011372:Progestins / Q000008:administration & dosage* / Q000652:urine*; D012825:Silicon; D014594:Uterine Neoplasms / Q000188:drug therapy
D003270:Contraceptive Agents; D003692:Delayed-Action Preparations; D011278:Pregnanes; D011372:Progestins; D008535:Megestrol; D012825:Silicon